Longevity Health Hldgs (XAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,822 | -3,392 | -1,506 | -10,651 | -9,736 |
| Depreciation Amortization | 177 | 139 | 74 | 217 | 178 |
| Accounts receivable | 34 | 26 | -14 | -4 | -15 |
| Accounts payable and accrued liabilities | -197 | 259 | 317 | -359 | -203 |
| Other Working Capital | 1,133 | 1,325 | 564 | 670 | 1,428 |
| Other Operating Activity | 653 | 54 | -188 | 5,739 | 5,227 |
| Operating Cash Flow | $-3,023 | $-1,589 | $-753 | $-4,389 | $-3,121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -150 | -150 | -150 | -749 | -749 |
| Other Investing Activity | 0 | -15 | 0 | 0 | 0 |
| Investing Cash Flow | $-164 | $-165 | $-150 | $-749 | $-749 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 496 | N/A |
| Debt Repayment | -345 | -249 | -122 | -714 | -592 |
| Common Stock Issued | 4,484 | 3,398 | 1,638 | 2,687 | 2,687 |
| Other Financing Activity | 0 | 0 | 0 | -86 | 0 |
| Financing Cash Flow | $4,139 | $3,148 | $1,516 | $2,382 | $2,095 |
| Beginning Cash Position | 157 | 157 | 157 | 2,913 | 2,913 |
| End Cash Position | 1,109 | 1,551 | 770 | 157 | 1,137 |
| Net Cash Flow | $952 | $1,394 | $613 | $-2,755 | $-1,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,023 | -1,589 | -753 | -4,389 | -3,121 |
| Capital Expenditure | -14 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,037 | -1,589 | -753 | -4,389 | -3,121 |